logo

Slide Shows

Share
Events

Biotech Stocks Facing FDA Decision In September 2021 As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.

Biotech Stocks Facing FDA Decision In August 2021 As of this writing, the FDA has approved four novel drugs in the month of July, bringing the total number of approvals so far this year to 31.

Ten Most Valuable Companies In The US The ten most valuable companies in the U.S., based on market capitalization, are worth over $11 trillion in total.

Biotech Stocks Facing FDA Decision In July 2021 In June, as of this writing, two novel drugs have secured the FDA nod – Brexafemme and Aduhelm.